Iol Chemicals Pharmaceuticals Ltd vs Neuland Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of IOL Chemicals & Pharmaceuticals Ltd is ₹ 108.24 as of 18 May 16:01 . The P/E Ratio of IOL Chemicals & Pharmaceuticals Ltd changed from 12.4 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Neuland Laboratories Ltd changed from 20.8 on March 2022 to 33.4 on March 2021 . This represents a CAGR of 9.94% over 5 years The Market Cap of IOL Chemicals & Pharmaceuticals Ltd changed from ₹ 2077 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Neuland Laboratories Ltd changed from ₹ 1317 crore on March 2022 to ₹ 2678 crore on March 2021 . This represents a CAGR of 15.26% over 5 years The revenue of IOL Chemicals & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 585.68 crore. This represent the decline of -100% The revenue of Neuland Laboratories Ltd for the Mar '26 is ₹ 788.71 crore as compare to the Dec '25 revenue of ₹ 447.76 crore. This represent the growth of 76.15% The ebitda of IOL Chemicals & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 51.36 crore. This represent the decline of -100% The ebitda of Neuland Laboratories Ltd for the Mar '26 is ₹ 319.79 crore as compare to the Dec '25 ebitda of ₹ 85.19 crore. This represent the growth of 275.38% The net profit of IOL Chemicals & Pharmaceuticals Ltd changed from ₹ 29.97 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Neuland Laboratories Ltd changed from ₹ 97.87 crore to ₹ 212.67 crore over 8 quarters. This represents a CAGR of 47.41% The Dividend Payout of IOL Chemicals & Pharmaceuticals Ltd changed from 7.92 % on March 2021 to 23.25 % on March 2025 . This represents a CAGR of 24.03% over 5 yearsThe Dividend Payout of Neuland Laboratories Ltd changed from 8.03 % on March 2021 to 5.97 % on March 2025 . This represents a CAGR of -5.76% over 5 years .

About IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active Pharmaceutical Ingredient (API) and specialty chemicals sectors.
Its extensive expertise in both API and specialty chemicals strengthens the business model and opens doors to diversified growth opportunities. Within the API segment, IOL develops and supplies a wide range of essential products utilized by pharmaceutical companies worldwide for the production of key medicines.
It serves as a global supplier of various APIs, including Ibuprofen, Metformin, Clopidogrel, Lamotrigine, Pantoprazole, and Fenofibrate, alongside other APIs, and maintains a significant presence in all major therapeutic categories. In the Specialty Chemicals division, IOL manufactures Ethyl Acetate, Iso Butyl Benzene (IBB), Mono Chloro Acetic Acid (MCA), and Acetyl Chloride.

About Neuland Laboratories Ltd

Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
The Company is engaged in manufacturing and selling of bulk drugs such as Salbutamol Sulphate, Terbutaline Sulphate, Labetalol Hydrochloride and Ciprofloxacin.
Neuland Drugs & Pharmaceuticals Pvt.
Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.

FAQs for the comparison of IOL Chemicals & Pharmaceuticals Ltd and Neuland Laboratories Ltd

Which company has a larger market capitalization, IOL Chemicals & Pharmaceuticals Ltd or Neuland Laboratories Ltd?

Market cap of IOL Chemicals & Pharmaceuticals Ltd is 3,109 Cr while Market cap of Neuland Laboratories Ltd is 21,260 Cr

What are the key factors driving the stock performance of IOL Chemicals & Pharmaceuticals Ltd and Neuland Laboratories Ltd?

The stock performance of IOL Chemicals & Pharmaceuticals Ltd and Neuland Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for IOL Chemicals & Pharmaceuticals Ltd and Neuland Laboratories Ltd?

As of May 18, 2026, the IOL Chemicals & Pharmaceuticals Ltd stock price is INR ₹105.92. On the other hand, Neuland Laboratories Ltd stock price is INR ₹16570.7.

How do dividend payouts of IOL Chemicals & Pharmaceuticals Ltd and Neuland Laboratories Ltd compare?

To compare the dividend payouts of IOL Chemicals & Pharmaceuticals Ltd and Neuland Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.